Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation.
about
Stat1 associates with c-kit and is activated in response to stem cell factorThe Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal FoldInterleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytesA plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiationYin-yang 1 and glucocorticoid receptor participate in the Stat5-mediated growth hormone response of the serine protease inhibitor 2.1 geneTyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activitySTAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinaseThreading analysis suggests that the obese gene product may be a helical cytokine.STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activationStromelysin-1 regulates adipogenesis during mammary gland involutionCloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis.Growth hormone rapidly activates rat serine protease inhibitor 2.1 gene transcription and induces a DNA-binding activity distinct from those of Stat1, -3, and -4.A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase.Phagocytosis mediated by Yersinia invasin induces collagenase-1 expression in rabbit synovial fibroblasts through a proinflammatory cascade.Thrombopoietin activates a STAT5-like factor in hematopoietic cells.Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription.Intracellular tyrosine residues of the human growth hormone receptor are not required for the signaling of proliferation or Jak-STAT activation.Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone.Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.Pbx1 is required for Hox D3-mediated angiogenesis.Other kinases can substitute for Jak2 in signal transduction by interferon-gamma.The regulation of protein transport to the nucleus by phosphorylation.Induction of early response genes by interferons, interleukins, and growth factors by the tyrosine phosphorylation of latent transcription factors. Implications for chronic inflammatory diseases.Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.Interferon response pathways--a paradigm for cytokine signalling?Participation of JAK and STAT proteins in growth hormone-induced signaling.Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of Jak2 and Stat proteins.The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of Stat 3.Signal transduction by a CD16/CD7/Jak2 fusion protein.Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells.Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5.Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency.Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption.
P2860
Q24530497-48AD7205-6FEA-4671-9521-5BA1CE3FFD30Q27677595-6B2B252B-2F57-415F-AB80-21754C367CE4Q28295404-ED75BF99-60CE-4663-9D14-B5A1E4C52B9EQ28357136-D36F9E40-F1CD-494B-8135-B7449CB755B2Q28573128-5F30B3A0-B195-4B5A-B79A-1612F63D1D81Q28610814-258DEBF8-8BB6-43A3-BDC3-5EC59E11D3D8Q34034959-5BB86077-14D8-4D42-A848-012078928C96Q34087183-210F28B8-384D-4F8D-A051-626E200B1CB4Q34297818-B4827659-B8D5-4563-BCA1-DAB3B0886D61Q34768271-CFBAA6C7-9521-4E5A-A5A8-81C1ABDD1EF5Q35850147-90C6AE70-2A83-4E52-AE74-56182779156EQ36375815-A9ABBFF4-9A04-4254-A088-7409AC9941F0Q36551756-023618FA-0363-4DEA-8487-85FB5B39B3EDQ36566246-7EFEF2F8-C828-4E9A-B50F-36A37A5FB878Q36855056-0851C922-D6EE-4F43-A9B2-7CF523B35854Q37460412-15645C98-4824-47AF-AAC0-2F09DA18ECACQ37698575-E836C2AC-6AC7-4C6F-9925-8467A131315EQ38292693-D0CE0651-0399-40DE-BFB4-BB189D39B03CQ38294444-56F82C70-CE35-4820-B1C8-E92C73ABD724Q38297370-DDF964F6-B1F5-4219-8B60-E87DB8AA1431Q38298544-F46E4E2F-4573-4486-99B8-88971C72DF71Q38301684-74A88AFB-341B-4359-A850-8AB7DADBE700Q38318081-191D2E90-5374-44D2-8045-8D7137D9309FQ38355174-EE09E187-8ECE-447E-80A3-8FB6C70B832DQ40375235-0268F311-BFD7-4BDC-9E5E-AB7B9CCDA374Q40402460-F6D8519D-0E78-4E16-9D5F-38AEA2175147Q40806604-E31C2458-CE7A-4CA7-8D98-30B96E95E89EQ41098851-269F3204-0ECC-4F89-8025-A2B4148CAFF7Q41217245-5DDDEEE7-1A0B-483F-B846-604D22D33FC1Q41296526-F4DF3950-E28A-44C5-BCEE-AE19F1DE1B0AQ41313217-4C1AFC33-5EE9-44FD-8792-7FEBBACEBAF4Q41313560-CDA0A01C-A4D7-4839-AE11-39D0E1A9B79FQ41326609-5F88D0A6-DCC2-444E-978F-15B6357DEF55Q41349290-96CBE001-36E6-4137-AEAE-8CB33ED04B13Q45101679-2C8AE970-F315-42B5-A104-2C76F0105640Q46450503-571A488E-D478-41AA-89A0-8000960B6F97Q52197267-866F516D-010A-48EC-B819-3016DB512BE7Q52534146-0B8F9519-A28E-4601-B20F-0D28CEA29F84
P2860
Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Growth hormone and erythropoie ...... s by tyrosine phosphorylation.
@ast
Growth hormone and erythropoie ...... s by tyrosine phosphorylation.
@en
type
label
Growth hormone and erythropoie ...... s by tyrosine phosphorylation.
@ast
Growth hormone and erythropoie ...... s by tyrosine phosphorylation.
@en
prefLabel
Growth hormone and erythropoie ...... s by tyrosine phosphorylation.
@ast
Growth hormone and erythropoie ...... s by tyrosine phosphorylation.
@en
P2093
P2860
P356
P1476
Growth hormone and erythropoie ...... s by tyrosine phosphorylation.
@en
P2093
D S Finbloom
E F Petricoin
G M Feldman
K Igarashi
M O Thorner
R H Hackett
P2860
P304
P356
10.1128/MCB.14.3.2113
P407
P577
1994-03-01T00:00:00Z